<DOC>
	<DOCNO>NCT00663793</DOCNO>
	<brief_summary>We propose study determine single-dose pharmacokinetics two novel formulation testosterone normal men experimentally induce hypogonadism .</brief_summary>
	<brief_title>ORAL T-6 : Oral Androgens Man-6</brief_title>
	<detailed_description>This 2-3 month open-label , two week pharmacokinetic study two novel formulation oral testosterone ( T ) , normal men whose endogenous T production temporarily suppress administration potent GnRH antagonist Acyline . We determine relative pharmacokinetics six different oral formulation T rapid slow release compare immediate release preparation study previously group .</detailed_description>
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Finasteride</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Androgens</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>male 18 50 year age good general health base normal screening evaluation must agree participate another research drug study participation must agree donate blood study must willing comply study protocol procedure must agree use acceptable form contraception agrees take medication study drug duration study Subject poor health , determine medical history physical lab result know history current use alcohol , drug steroid abuse and/or use 3 alcohol beverage per day Participation longterm contraceptive study within past two month History bleed disorder current use anticoagulant History sleep apnea and/or major psychiatric disorder</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Male Contraception</keyword>
	<keyword>Hypogonadism</keyword>
	<keyword>Testosterone</keyword>
</DOC>